Literature DB >> 13795753

Antimalarial compounds in rheumatoid disease.

A W BAGNALL.   

Abstract

Entities:  

Keywords:  ANTIMALARIALS/therapy

Mesh:

Substances:

Year:  1960        PMID: 13795753      PMCID: PMC1938458     

Source DB:  PubMed          Journal:  Can Med Assoc J        ISSN: 0008-4409            Impact factor:   8.262


× No keyword cloud information.
  6 in total

1.  Corneal complication of chloroquine (aralen) phosphate therapy.

Authors:  R W ZELLER; D DEERING
Journal:  J Am Med Assoc       Date:  1958-12-27

2.  Retinopathy following chloroquine therapy.

Authors:  H E HOBBS; A SORSBY; A FREEDMAN
Journal:  Lancet       Date:  1959-10-03       Impact factor: 79.321

3.  Amodiaquine and hydroxychloroquine in rheumatoid arthritis.

Authors:  G D KERSLEY; A G PALIN
Journal:  Lancet       Date:  1959-11-21       Impact factor: 79.321

4.  The value of chloroquine in rheumatoid disease: a four-year study of continuous therapy.

Authors:  A W BAGNALL
Journal:  Can Med Assoc J       Date:  1957-08-01       Impact factor: 8.262

5.  Further observations on the use of 4-aminoquinoline compounds in patients with rheumatoid arthritis or related diseases.

Authors:  A L SCHERBEL; J W HARRISON; M ATDJIAN
Journal:  Cleve Clin Q       Date:  1958-04

6.  The ocular complications of chloroquine therapy.

Authors:  H E HOBBS; C D CALNAN
Journal:  Lancet       Date:  1958-06-07       Impact factor: 79.321

  6 in total
  1 in total

1.  THE VALUE AND DANGERS OF ANTIMALARIAL THERAPY IN ARTHRITIS WITH SPECIAL RELATION TO OPHTHALMIC COMPLICATIONS.

Authors:  G D KERSLEY
Journal:  Proc R Soc Med       Date:  1964-08
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.